Bernhard H. Geierstanger, Ph.D.

Co-founder and Chief Technology Officer at Firefly Biologics

Speaker

Bernhard Geierstanger is CTO and co-founder of FireflyBio, a bay area ADC startup. He is an expert in protein engineering, ADCs and biotherapeutics. Before FireflyBio, he worked at Merck (MRL) and the Genomics Institute of the Novartis Research Foundation (GNF) leading teams that develop innovative biotherapeutics. Several of these have advanced to clinical trials. He has also pioneered novel methods for protein modification, site-specific conjugation, and the use of immune stimulating ADC payloads.

Bernhard holds a Ph.D. in Biophysics from UC Berkeley and was a postdoctoral fellow at Stanford University. He has authored >60 publications and is an inventor on >30 patents and patent applications.